The demand for indemnification agreements by Covid-19 vaccine manufacturers is not related to the Dengvaxia controversy, the Department of Health (DoH) said.

Health Undersecretary Maria Rosario Vergeire. Screengrab from DOH Beat COVID-19 Press Conference

Subscribe to unlock this article
Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
Subscribe to the Premium + Digital Edition Plan
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details